Asia Pacific Collagen Peptides Market
Asia Pacific Collagen Peptides Market is growing at a CAGR of 7.0% to reach US$ 386.68 million by 2030 from US$ 241.14 million in 2023 by Source, Form, Application.

Published On: Aug 2023

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Collagen Peptides Market

At 7.0% CAGR, the Asia Pacific Collagen Peptides Market is projected to be worth US$ 386.68 million by 2030, says The Business Market Insights

According to the Business Market Insights’ research, the Asia Pacific Collagen Peptides Market was valued at US$ 241.14 million in 2023 and is expected to reach US$ 386.68 million by 2030, registering a CAGR of 7.0% from 2023 to 2030. Wide application scope and strategic development initiatives by key market players are the critical factors attributed to the Asia Pacific collagen peptides market expansion.                    

Marine organisms such as fish, jellyfish, sponges, and other invertebrates harbor a significant source of collagen peptides. They are highly advantageous over other sources, as they are metabolically compatible, lack religious constraints, and are free of animal pathogens. Marine-sourced collagen peptide is majorly used for skincare product manufacturing. It is a versatile compound capable of healing skin injuries of varying severity and delaying the natural human aging process. Moreover, marine-sourced collagen peptides can be used as a biomaterial owing to its water solubility and metabolic compatibility. Thus, the demand for marine-sourced collagen peptide is increasing with its rising utilization for different industrial applications.

Furthermore, marine-sourced collagen peptides do not foster transmissible diseases. Land animals possess many transmissible diseases, making them less favorable for industry use. For example, cattle, although a large source of collagen, pose risks for BSE and TSE. These progressive neurological disorders affect cattle and can result in life-threatening human infections. In addition, a few religious constraints on using bovines for the pharmaceutical and cosmetic industries are up for debate. These factors make marine sources of collagen peptides a much easier, safer, and more promising alternative. Thus, with increasing demand, manufacturers are launching different products. For instance, in January 2021, Darling Ingredients introduced Peptan, a marine collagen peptide under its Rousselot brand. This product helps the company to enter the dietary supplements market. Thus, the growing demand for marine-sourced collagen is expected to open new opportunities in the collagen peptides market during the forecast period.  

On the contrary, safety concerns and stringent regulations related to consumption of collagen peptides hurdles the growth of Asia Pacific collagen peptides market. 

Based on sources, the Asia Pacific collagen peptides market is segmented into bovine, porcine, poultry, marine, and others. The bovine segment held 34.9% share of Asia Pacific collagen peptides market in 2023, amassing US$ 84.05 million. It is projected to garner US$ 129.25 million by 2030 to expand at 6.3% CAGR during 2023–2030.

Based on form, the Asia Pacific collagen peptide market is segmented into dry and liquid. The dry segment held 86.8% share of Asia Pacific collagen peptides market in 2023, amassing US$ 209.36 million. It is projected to garner US$ 338.20 million by 2030 to expand at 7.1% CAGR during 2023–2030.

Based on application, the Asia Pacific collagen peptide market is segmented into food & beverages, pharmaceuticals & nutraceuticals, personal care, and others. The pharmaceuticals & nutraceuticals segment held 35.9% share of Asia Pacific collagen peptide market in 2023, amassing US$ 86.59 million. It is projected to garner US$ 135.23 million by 2030 to expand at 6.6% CAGR during 2023–2030.  

Based on country, the Asia Pacific collagen peptide market has been categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Our regional analysis states that the Rest of Asia Pacific captured 29.9% share of Asia Pacific collagen peptide market in 2023. It was assessed at US$ 72.13 million in 2023 and is likely to hit US$ 107.80 million by 2030, exhibiting a CAGR of 5.9% during the forecast period.      

Key players dominating the Asia Pacific collagen peptide market are GELITA AG; Nippi Collagen NA Inc; Nitta Gelatin India Ltd; Rousselot BV; Tessenderlo Group NV; Titan Biotech Ltd; and Weishardt Holding SA among others. 

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com